Imagion Biosystems Limited (IBX.AX)

AUD 0.01

(-7.14%)

Net Debt Summary of Imagion Biosystems Limited

Imagion Biosystems Limited's latest annual net debt in 2023 was 5.81 Million AUD , up 3571.81% from previous year.
Imagion Biosystems Limited's latest quarterly net debt in 2024 Q1 was 2.78 Million AUD , down -52.04% from previous quarter.
Imagion Biosystems Limited reported annual net debt of 158.26 Thousand AUD in 2022, up 101.19% from previous year.
Imagion Biosystems Limited reported annual net debt of -13.34 Million AUD in 2021, down -6.45% from previous year.
Imagion Biosystems Limited reported quarterly net debt of 2.78 Million AUD for 2024 Q1, down -52.04% from previous quarter.
Imagion Biosystems Limited reported quarterly net debt of 5.36 Million AUD for 2023 Q2, up 30.35% from previous quarter.

Annual Net Debt Chart of Imagion Biosystems Limited (2023 - 2014)

Historical Annual Net Debt of Imagion Biosystems Limited (2023 - 2014)

Year	Net Debt	Net Debt Growth
2023	5.81 Million AUD	3571.81%
2022	158.26 Thousand AUD	101.19%
2021	-13.34 Million AUD	-6.45%
2020	-12.53 Million AUD	-396.63%
2019	-2.52 Million AUD	41.45%
2018	-4.31 Million AUD	36.51%
2017	-6.79 Million AUD	-437.27%
2016	2.01 Million AUD	-77.88%
2015	9.1 Million AUD	126.13%
2014	4.02 Million AUD	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	2.78 Million AUD	0.75%
2024 Q1	2.78 Million AUD	-52.04%
2023 Q2	5.36 Million AUD	30.35%
2023 Q1	4.11 Million AUD	2500.19%
2023 Q4	5.81 Million AUD	23.23%
2023 Q3	4.71 Million AUD	-12.09%
2023 FY	5.81 Million AUD	3571.81%
2022 Q4	158.26 Thousand AUD	117.93%
2022 Q2	-3.39 Million AUD	24.99%
2022 FY	158.26 Thousand AUD	101.19%
2022 Q3	-882.78 Thousand AUD	74.03%
2022 Q1	-4.53 Million AUD	66.13%
2021 Q1	-13.89 Million AUD	-10.77%
2021 FY	-13.34 Million AUD	-6.45%
2021 Q2	-13.73 Million AUD	1.13%
2021 Q4	-13.37 Million AUD	-0.12%
2021 Q3	-13.36 Million AUD	2.69%
2020 Q4	-12.53 Million AUD	2.78%
2020 Q1	-3.87 Million AUD	-53.49%
2020 Q2	-3.58 Million AUD	7.56%
2020 FY	-12.53 Million AUD	-396.63%
2020 Q3	-12.89 Million AUD	-260.04%
2019 Q3	-2.78 Million AUD	-152.57%
2019 Q1	-1.12 Million AUD	73.99%
2019 FY	-2.52 Million AUD	41.45%
2019 Q2	-1.1 Million AUD	1.64%
2019 Q4	-2.52 Million AUD	9.39%
2018 Q3	-4.34 Million AUD	-22.34%
2018 Q1	-3.55 Million AUD	47.67%
2018 FY	-4.31 Million AUD	36.51%
2018 Q4	-4.31 Million AUD	0.83%
2018 Q2	-3.55 Million AUD	0.0%
2017 Q1	-12.27 Million AUD	0.0%
2017 Q4	-6.79 Million AUD	0.45%
2017 Q3	-6.82 Million AUD	44.41%
2017 Q2	-12.27 Million AUD	0.0%
2017 FY	-6.79 Million AUD	-437.27%
2016 FY	2.01 Million AUD	-77.88%
2015 FY	9.1 Million AUD	126.13%
2014 FY	4.02 Million AUD	0.0%

Peer Net Debt Comparison of Imagion Biosystems Limited

Name	Net Debt	Net Debt Difference
Australian Clinical Labs Limited	282.76 Million AUD	97.945%
BCAL Diagnostics Limited	-5.83 Million AUD	199.65%
Genetic Signatures Limited	-35.03 Million AUD	116.589%
Genetic Technologies Limited	-377.06 Thousand AUD	1641.195%
Healius Limited	1.53 Billion AUD	99.622%
Integral Diagnostics Limited	315.35 Million AUD	98.157%
INOVIQ Ltd	-8.69 Million AUD	166.81%
Microba Life Sciences Limited	-20.49 Million AUD	128.356%
Monash IVF Group Limited	48.23 Million AUD	87.951%
Rhythm Biosciences Limited	-545.67 Thousand AUD	1164.97%
Sonic Healthcare Limited	3.87 Billion AUD	99.85%